Gilead Sciences
Price & Volume
Stats
See more52W Range | $105.01-$155.38 |
Market Cap | $161.1B |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $29.7B |
Revenue Growth (YoY) | 4.4% |
Gross Profit (12 Mos) | $23.6B |
Diluted EPS | $7.35 |
News
See moreYahoo Finance • 2 days ago
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
Yahoo Finance • 3 days ago
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?
Yahoo Finance • 3 days ago
Which is the Better Choice for Healthcare Investors? IYH or BBH?
Yahoo Finance • 4 days ago
2 Recession-Resistant Dividend Stocks to Buy and Hold
About
CEO | Mr. Daniel Patrick O'Day |
CFO | Mr. Andrew D. Dickinson |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,000 |